Merck & Co., Inc. 4
4 · Merck & Co., Inc. · Filed May 20, 2016
Insider Transaction Report
Form 4
Golestani Clark
EVP & Chief Info Officer
Transactions
- Sale
Common Stock
2016-05-19$54.55/sh−1,230$67,097→ 17,083 total - Exercise/Conversion
Common Stock
2016-05-20$44.98/sh+38,647$1,738,342→ 55,730 total - Sale
Common Stock
2016-05-20$54.80/sh−38,647$2,117,856→ 17,083 total - Exercise/Conversion
Stock Option (right to buy)
2016-05-20−38,647→ 0 totalExercise: $44.98From: 2014-05-06Exp: 2023-05-05→ Common Stock (38,647 underlying)
Holdings
- 9,349.053(indirect: By 401(k))
Common Stock - 401(k) Plan
Footnotes (3)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Includes shares acquired and dividends earned through April 7, 2016, in the Merck U.S. Savings Plan, a 401(k) plan.
- [F3]The option became exercisable in equal installments on 5/6/2014, 5/6/2015 and 5/6/2016.